Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O F Ramos

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Immunobiology|December 1, 1983
The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytesO F Ramos, M G Masucci, M T Bejarano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targetsO F Ramos, I Algarra, G Sármay, et al.
European Journal of Immunology|July 1, 1987
Alternative pathway of complement activation by stimulated T lymphocytes. II. Elevation of cytotoxic potential against complement receptor-carrying cell linesO F Ramos, G Sármay, G Eggertsen, et al.
Cellular Immunology|April 1, 1989
Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragmentsO F Ramos, B Nilsson, K Nilsson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Immunobiology|December 1, 1983
The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytesO F Ramos, M G Masucci, M T Bejarano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targetsO F Ramos, I Algarra, G Sármay, et al.
European Journal of Immunology|July 1, 1987
Alternative pathway of complement activation by stimulated T lymphocytes. II. Elevation of cytotoxic potential against complement receptor-carrying cell linesO F Ramos, G Sármay, G Eggertsen, et al.
Cellular Immunology|April 1, 1989
Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragmentsO F Ramos, B Nilsson, K Nilsson, et al.
Pageof 2